Review-State-Aware Comparison
Andrographis vs Bolivian Passionfruit
An automated side-by-side view of two public profiles. It has not been individually curated as a clinical comparison and is excluded from search indexing. Scores and narratives are provisional unless a profile explicitly states human approval; no personal dosage or combination conclusion is provided.
This page cannot establish which ingredient is better, whether either is effective, or whether they can be combined safely. Editorial and quality-gate review approved this evidence record. Editorial and quality-gate review approved this evidence record.
Andrographis
Human-reviewed public score: 10/10
Bolivian Passionfruit
Human-reviewed public score: 10/10Human-Reviewed Benefit Text
Andrographis
Bolivian Passionfruit
Human-Reviewed Mechanism Text
Andrographolide and related compounds inhibit NF-κB transcriptional activity with IC₅₀ values of 2-2.4 μg/mL, reducing production of TNF-α, IL-6, MIP-2, and nitric oxide in stimulated macrophages. The herb blocks JAK/STAT signaling by inhibiting STAT1/2/3 phosphorylation and PI3K pathways while inducing apoptosis through caspase-3 activation and BAX upregulation. Additional mechanisms include Nrf2/HO-1 antioxidant pathway activation and ROS reduction via PKC modulation.
Flavonoids including quercetin and kaempferol derivatives scavenge free radicals through electron donation, while carotenoids like beta-carotene quench singlet oxygen species. The fruit's soluble and insoluble fiber fractions modulate gut microbiome composition and promote short-chain fatty acid production. Potassium content supports cardiovascular function through sodium-potassium pump regulation and vascular smooth muscle relaxation.
Human-Reviewed Safety Text
Current research lacks comprehensive safety data, drug interaction profiles, and specific contraindications for andrographis supplementation. The bitter taste may cause gastrointestinal discomfort in sensitive individuals, and the herb's immunomodulatory effects could theoretically interact with immunosuppressive medications. Pregnant and breastfeeding women should avoid use due to insufficient safety data and potential uterine stimulant properties. Patients on anticoagulant medications should exercise caution as andrographis may affect bleeding time, though specific interaction studies are not well-documented.
Passiflora species are generally well-tolerated with rare reports of allergic reactions in sensitive individuals. The fruit may interact with anticoagulant medications due to vitamin K content, though clinically significant interactions are uncommon. High fiber intake may cause gastrointestinal discomfort including bloating or loose stools in sensitive individuals. Pregnancy and lactation safety data is limited, requiring caution in these populations despite traditional food use.
Comparison summary
This automated view does not establish that either Andrographis or Bolivian Passionfruit is effective, superior, suitable, or safe to combine. Both have the same provisional public score (10/10). This ordering does not establish clinical superiority, safety, or suitability. Use the linked profiles and a qualified healthcare professional for decisions.
Frequently Asked Questions
Is Andrographis or Bolivian Passionfruit better?
Andrographis and Bolivian Passionfruit have the same provisional public score (10/10). A score tie does not establish equivalent evidence or outcomes.
Can you take Andrographis and Bolivian Passionfruit together?
No reviewed combination conclusion is established by this comparison. A missing reviewed interaction record means unknown, not safe. Consult a qualified healthcare professional before combining supplements.
What is the main difference between Andrographis and Bolivian Passionfruit?
Andrographis is categorized as herb (botanical), while Bolivian Passionfruit is categorized as fruit (Compound). Category labels are classification fields, not evidence of benefit; claim-bearing text appears only when both profiles have recorded human approval.
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.